BioSpace News Archive

Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions for healthcare providers, announced that it has welcomed Mr. David Madaffri to the company as its new Senior Vice President of Global Sales.

Besides causing much illness and death, the SARS-CoV-2 virus with its COVID-19 disease has been a major ally of those seeking to impose a radical collectivist ideology and to expand their control of our lives at any cost, writes Marilyn Singleton, M.D., J.D., in the summer issue of the Journal of American Physicians and Surgeons.

Not long ago, board certification of physicians simply documented achievement of a certain level of specialty training, but recently it has become time-limited.

After the post-vaccination death of a 56-year-old Florida physician from a brain hemorrhage, and reports of clotting problems worldwide after the Astra-Zeneca jab, Lee Merritt, M.D., undertook a review of reports in the Vaccine Adverse Event Reporting System of reactions to Pfizer and Moderna products that possibly were related to platelet problems.

In medical settings, power cut-offs are not merely an inconvenience but can be a life-or-death issue.

A study published in the Journal of Clinical Psychopharmacology found that an FDA cleared, computer-based, objective measurement of attention-deficit/hyperactivity disorder (ADHD) symptoms was more sensitive to medication effects than patient self-rating, at both one-month and six-month follow-up visits

Greg Kunst has been named chief executive officer of newly-launched Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies to treat ocular diseases.

DiFusion Technologies, maker of the ZFUZE™ suite of surgical polymers, today announced the addition of Todd Potokar to its Board of Directors.

Medidata, a Dassault Systèmes company, today launched myMedidata Registries, a new technology that expands and strengthens the myMedidata patient portal to engage patients before and after (i.e., long term follow up/safety surveillance) a clinical trial.

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company at the forefront of stem cell-based delivery of oncolytic viruses, announced today its partnership with GenScript ProBio.